| Date |
Research Question / Title |
Unique ID |
Research Team |
|
March 24, 2020
|
What is the risk of reinfection from COVID-19?
|
EOC032401-01 ESR
|
EOC
|
|
March 31, 2020
|
What percentage of COVID-19 patients have hyposmia or anosmia?
|
EOC033102-01 ESR
|
EOC
|
|
April 7, 2020
|
What is the prevalence of sore throat as a symptom of COVID-19?
|
EOC040201 RR
|
EOC
|
|
April 7, 2020
|
What is the prevalence of sore throat as a symptom of COVID-19?
|
EOC040201-01 ESR
|
EOC
|
|
April 8, 2020
|
Is the IgM or IgG immune response protective?
|
LAB040803-01 ESR
|
Laboratory
|
|
April 11, 2020
|
Is the IgM or IgG immune response protective?
|
LAB040803 RR
|
Laboratory
|
|
April 14, 2020
|
At what time in the disease timeline of COVID-19 do antibodies develop?
|
LAB041402-01 ESR
|
Laboratory
|
|
April 15, 2020
|
At what time in the disease timeline of COVID-19 do antibodies develop?
|
LAB041402 RR
|
Laboratory
|
|
May 8, 2020
|
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
|
LAB040701v2 RR
|
Laboratory
|
|
May 8, 2020
|
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
|
LAB040701v2-01 ESR
|
Laboratory
|
|
May 11, 2020
|
What percentage of COVID-19 patients have hyposmia or anosmia?
|
EOC033102 RR
|
EOC
|
|
May 12, 2020
|
What are the risk factors for severity and death associated with COVID-19?
|
EPM050901-01 ESR
|
Epidemiology & Modelling
|
|
May 19, 2020
|
What are the risk factors for severity and death associated with COVID-19?
|
EPM050901 RR
|
Epidemiology & Modelling
|
|
May 19, 2020
|
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
|
LAB041601v2 RR
|
Laboratory
|
|
May 22, 2020
|
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
|
LAB041601v2-01 ESR
|
Laboratory
|
|
September 25, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401-01 ESR
|
EOC
|
|
September 29, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401 RR
|
EOC
|
|
September 30, 2020
|
Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients?
|
INF092801-01 ESR
|
Infectious Disease
|
|
October 15, 2020
|
Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients?
|
INF092801 RR
|
Infectious Disease
|
|
November 2, 2020
|
What is the risk of reinfection from COVID-19? [Update]
|
EOC032401v3 RR
|
EOC
|
